Rifaximin - CISMeF

Preferred Label : Rifaximin;

NCIt definition : An orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. Rifaximin binds to the beta-subunit of bacterial DNA-dependent RNA polymerase, inhibiting bacterial RNA synthesis and bacterial cell growth. As rifaximin is not well absorbed, its antibacterial activity is largely localized to the gastrointestinal tract.;

UNII : L36O5T016N;

InChIKey : NZCRJKRKKOLAOJ-XRCRFVBUSA-N;

CAS number : 80621-81-4;

Drug name : Xifaxan;

Chemical formula : C43H51N3O11;

Details

Origin ID

C61926;

UMLS CUI

C0073374;

Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing rifaximin (medicinal product) [SNOMED CT concept]
- Rifaximin [MeSH Descriptor]
- Rifaximin [ICD-11 Extension code]
- Rifaximin (substance) [SNOMED CT concept]
- rifAXIMin [LOINC component]
- rifaximin [ATC Code]
- rifaximin [ATC Code]
- rifaximin [MeSH concept]
Validated automatic mappings to BTNT
- rifaximin [ATC Code]
- rifaximin [ATC Code]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients